Vivodyne co-founders (L-R): CEO Andrei Georgescu and CSO Dan Huh
Khosla Ventures leads $38M seed round for organoid startup Vivodyne
Khosla Ventures is leading a seed round for a new biotech that aims to use artificial intelligence to jump into the world of organoids. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
